Skip to main content
. Author manuscript; available in PMC: 2009 Dec 2.
Published in final edited form as: Clin Cancer Res. 2008 Dec 1;14(23):7896–7899. doi: 10.1158/1078-0432.CCR-08-0418

Table 1.

Demographics of patients and distribution of FAS genotypes

Characteristic GG (N=347) GA (N=81) AA (N=12) GG vs
GA
GA vs
AA
GG vs
AA
N % N % N % P P P

Age: median & range (yrs) 9.4 (0.01 – 20.9) 11.5 (0.47 – 19.0) 10.1 (1.64 – 16.2) 0.12 0.99 0.50
WBC: median & range 20600 (1000 –860000) 18400 (300 – 373300) 17700 (1500 –848000) 0.67 0.52 0.38
Study
CCG-2941 30 9% 6 7% 0 0% 0.89 1.00 0.61
CCG-2961 317 91% 75 93% 12 100%
Gender
Male 189 55% 49 61% 6 50% 0.39 0.54 0.99
Female 158 45% 32 39% 6 50%
Race
White 246 71% 54 67% 6 50% 0.52 0.34 0.19
Black 31 9% 4 5% 1 8% 0.34 0.51 1.00
Hispanic 49 14% 18 22% 1 8% 0.10 0.45 1.00
Asian 5 1% 4 5% 4 33% 0.07 0.01 <0.01
Other 15 4% 1 1% 0 0% 0.33 1.00 1.00
Unknown 1 0 0
Response at end of first
course
Remission 290 87% 71 90% 12 100% 0.55 0.59 0.38
PD 23 7% 7 9% 0 0% 0.71 0.59 1.00
Die 22 7% 1 1% 0 0% 0.10 1.00 1.00
W/D or unevaluable 12 2 0